Fraint Ellen, Abdel-Azim Hisham, Bhatt Neel S, Broglie Larisa, Chattha Asma, Kohorst Mira, Ktena Yiouli P, Lee Michelle A, Long Susie, Qayed Muna, Sharma Akshay, Stefanski Heather, Vatsayan Anant, Wray Lisa, Hamadani Mehdi, Carpenter Paul A
Division of Pediatric Hematology, Oncology, and Cellular Therapy, Children's Hospital at Montefiore, Bronx, New York.
Loma Linda University School of Medicine, Cancer Center, Children's Hospital and Medical Center, Loma Linda, California.
Transplant Cell Ther. 2023 May;29(5):293-301. doi: 10.1016/j.jtct.2023.02.003. Epub 2023 Feb 10.
Evaluation of a candidate for hematopoietic cell transplantation (HCT) is a complex process with substantial intercenter variability. Although literature providing guidance for evaluating the eligibility of adults is well established, similar guidance for children is lacking. To address gaps between adult recommendations and the specific needs of children, we convened a panel of pediatric HCT experts from a wide geographic range of American Society of Transplantation and Cellular Therapy (ASTCT) member institutions to offer recommendations for pediatric-focused pre-HCT evaluation. In this report from the ASTCT Committee on Practice Guidelines, we present a practical framework for evaluating children with malignancies who are candidates for HCT. We also highlight key differences from adults and emphasize areas of unmet need that require additional research to delineate best practices.
评估造血细胞移植(HCT)候选者是一个复杂的过程,各中心之间存在很大差异。虽然已有为评估成人资格提供指导的文献,但缺乏针对儿童的类似指导。为了弥合成人建议与儿童特殊需求之间的差距,我们召集了一个来自美国移植与细胞治疗学会(ASTCT)成员机构广泛地理区域的儿科HCT专家小组,以提供针对儿科的HCT前评估建议。在ASTCT实践指南委员会的这份报告中,我们提出了一个评估恶性肿瘤患儿HCT候选者的实用框架。我们还强调了与成人的关键差异,并强调了未满足的需求领域,这些领域需要更多研究来确定最佳实践。